Cargando…
Targeted Inhibition of miR-221/222 Promotes Cell Sensitivity to Cisplatin in Triple-Negative Breast Cancer MDA-MB-231 Cells
Cisplatin has been widely used in the treatment of a various types of cancers including triple-negative breast cancer (TNBC) by damaging DNA and inducing apoptosis. However, its anti-cancer effects are often limited due to chemo-resistance, which is one of the main reasons causing cancer relapse and...
Autores principales: | Li, Shujun, Li, Qun, Lü, Jinhui, Zhao, Qian, Li, Danni, Shen, Lei, Wang, Zhongrui, Liu, Junjun, Xie, Dongping, Cho, William C., Xu, Shaohua, Yu, Zuoren |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6971202/ https://www.ncbi.nlm.nih.gov/pubmed/32010177 http://dx.doi.org/10.3389/fgene.2019.01278 |
Ejemplares similares
-
Synergistic action of cisplatin and echistatin in MDA-MB-231 breast cancer cells
por: Czarnomysy, Robert, et al.
Publicado: (2016) -
Reck-Notch1 Signaling Mediates miR-221/222 Regulation of Lung Cancer Stem Cells in NSCLC
por: Guo, Yuefan, et al.
Publicado: (2021) -
Correlation between Slug transcription factor and miR-221 in MDA-MB-231 breast cancer cells
por: Lambertini, Elisabetta, et al.
Publicado: (2012) -
Isobavachalcone Induces Multiple Cell Death in Human Triple-Negative Breast Cancer MDA-MB-231 Cells
por: Wu, Cheng-Zhu, et al.
Publicado: (2022) -
Characterization of Triple-Negative Breast Cancer MDA-MB-231 Cell Spheroid Model
por: Huang, Zhaoming, et al.
Publicado: (2020)